European Companies Search Engine

43 EU fundings (€41M): EUROPEAN PARTNERSHIP FOR BRAIN HEALTH (EP BRAINHEALTH) … BdlYear 2025 EU Research and Innovation programme "Horizon"

Text

Siren 180036048

28/04/2025 EU funding: Neutrophil Extracellular Traps Induced Glial Type I Interferon in the Pathogenesis of Tauopathy
14/04/2025 EU funding: NITROGEN FIXATION FACILITATED BY HOPANOID PRODUCTION IN MARINE CYANOBACTERIAL DIAZOTROPHS
19/03/2025 EU funding: Unveiling lung resilience mechanisms: a ground-breaking way to cope with air pollution
01/10/2025 EU funding (€1,498,973): Beyond a snapshot: Spatiotemporal Multiomics for the study of Breast Cancer phenotypic transitions
10/11/2025 EU funding (€1,499,999): De-Coding Adhesion, Degradation and Immunomodulation Properties of Self-Assembling Peptide Hydrogels for Programmed Tendon Regeneration
01/10/2025 EU funding (€1,548,090): CliCBrain: Climate, Cities and Brain health; Addressing the impact of climate and exposome on brain health
07/03/2025 EU funding (€1,996,223): Evolutionary Arms Races Shaping the Germline Epigenome
26/03/2025 EU funding (€11M): Deep learning analysis of imaging and metabolomic data to accelerate antibiotic discovery against antimicrobial resistance
01/05/2025 EU funding (€13.6M): Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
22/12/2025 EU funding (€146.5M): EUROPEAN PARTNERSHIP FOR BRAIN HEALTH (EP BRAINHEALTH)
16/10/2025 EU funding (€150,000): A new generation of injectable implants based on Cell-Assembled extracellular Matrix (CAM)
07/01/2025 EU funding (€150,000): Intrinsic Microenvironment-Dependent Potentiation of Antibodies for Cancer Therapy
26/02/2025 EU funding (€150,000): Novel targeted intervention to prevent brain aneurysm rupture
26/02/2025 EU funding (€150,000): PAncreatic Cancer therapeutic discovery using Monoclonal ANtibodies
08/09/2025 EU funding (€150,000): Peptidomimetic therapy to promote central Nervous System repair
26/03/2025 EU funding (€151,413): Biological Factors in Fleas: Determinants of Physiology and Pathogen Transmission
31/03/2025 EU funding (€2,000,000): Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition
28/05/2025 EU funding (€2,000,000): Human-specific modifiers of synapses in development, plasticity and disorders
15/09/2025 EU funding (€2,296,090): Non-invasive recording of deep brain activity: mobile sensors optimized with intracerebral measures
14/07/2025 EU funding (€2,647,675): The role of cellular mechanical stress in the pathogenesis of neurodegenerative disorders
28/05/2025 EU funding (€2,999,894): Fostering Outermost regions Capabilities in Research and Innovation and Upgrading Skills complying with 4R principles
17/04/2025 EU funding (€226,421): Decisive early crosstalk in bone repair: vessel, nerve and stem cell interactions in healthy and Neurofibromatosis type 1 conditions
26/05/2025 EU funding (€226,421): Decoding the role of mitochondrial dynamics in the mesenchymal-to-amoeboid transition and melanoma metastasis
07/04/2025 EU funding (€226,421): GLI-AGE: Role of glial cells in age-related muscle sarcopenia and NMJ-disfunction.
01/06/2025 EU funding (€226,421): Investigating macrophage-nerve crosstalk in homeostasis and post-stroke spontaneous urinary tract infection
14/04/2025 EU funding (€242,261): (Mal)adaptative beta-adrenergic regulation of the cardiac voltage-gated sodium channel, Nav1.5
14/04/2025 EU funding (€242,261): Contribution of adipose tissue and liver to cachexia associated with chronic kidney disease
07/04/2025 EU funding (€242,261): Exploring the induction of trained immunity by anti-infective antibodies delivered directly to the respiratory tract, as a protective response against respiratory infection
05/06/2025 EU funding (€242,261): Extracellular vesicles: novel compartments for cAMP signaling
23/04/2025 EU funding (€242,261): Heat Exposure and Antihypertensive Treatment: Unravelling causal Pathways
07/04/2025 EU funding (€242,261): Noradrenergic Modulation of Hippocampal Post-Natal Development
23/04/2025 EU funding (€242,261): Towards the Engineering of High-Capacity Viral Vectors for Neuromuscular Diseases
31/03/2025 EU funding (€242,261): Uncovering the role of the m6A epitranscriptome in Myotonic Dystrophy Type 1 (DM1)
27/06/2025 EU funding (€4,051,542): Stem Cell Therapy Development for Corneal Epithelium Regeneration
14/07/2025 EU funding (€4,157,935): EURopean Epitranscriptomics of Cancer Academy
27/06/2025 EU funding (€4,300,707): INTEGRATE - Interdisciplinary Network for Training, Education, and Growing Research into Applications of and Therapeutic Expertise around Psychedelics
03/07/2025 EU funding (€4,393,218): Spatial Crosstalk in Immuno-Oncology
23/07/2025 EU funding (€4,476,069): Brain Health in Menopausal Women
26/05/2025 EU funding (€413,380): Accounting for human behaviour in risk assessments of zoonotic spillover and international spread of infectious diseases in scenarios of global change
23/05/2025 EU funding (€5,768,415): Telacebec to Control Buruli Ulcer and Leprosy in Africa (TEBULA)
31/07/2025 EU funding (€57.3M): BE READY NOW - EUROPEAN PARTNERSHIP FOR PANDEMIC PREPAREDNESS
28/05/2025 EU funding (€6,113,863): Integrated Multi-vector-borne diseases Platform to Assess how global Change impacts Transmission using Innovative systems modeling, Novel monitoring tools, and transmission blockinG micro-organisms
26/05/2025 EU funding (€6,329,134): Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicity

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Institut National de la Sante et de la Recherche Medicale, Paris, France.